Cancer Research UK Grants & Research: Douglas Altman

Selected Publications

Altman DG and De Stavola BL. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat. Med. 1994; 13: 301-341.

Altman DG, De Stavola BL, Love SB and Stepniewska KA. Review of survival analyses published in cancer journals. Br. J. Cancer 1995; 72: 511-518.

Royston P and Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl. Stat. 1994; 43: 429-467.

Sharp SJ, Thompson SG and Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. Br. Med. J. 1996; 313: 735-738.

Royston P and Altman DG. Approximating statistical functions by using fractional polynomial regression. Statistician 1997; 46: 411-422.

Primary Research Papers

Altman DG. Reporting of randomisation procedures. British Medical Journal, www.bmj.com/cgi/eletters/322/7279/134#EL1

Altman DG. Notation. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 205-207.

Altman DG. Randomisation in the SYMPHONY trial. Lancet 2000; 356: 1521.

Altman DG. Confidence interval for odds ratio. Physiotherapy Research International 2000; 5: 134-135.

Altman DG. Statistics in medical journals: some recent trends. Statistics in Medicine 2000; 19: 3275-3289.

Altman DG. Systematic reviews of evaluations of prognostic variables. In: Egger M, Davey Smith G, Altman DG (ed.) Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd ed. London: BMJ Books, 2001; 228-247.

Altman DG. Systematic reviews of evaluations of prognostic variables. British Medical Journal 2001; 323: 224-228.

Altman DG, Deeks JJ. Comments on the paper by Hutton. Journal of the Royal Statistical Society Series A-Statistics in Society 2000; 163: 415-416.

Altman DG, Gardner MJ. Means and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 28-35.

Altman DG, Gardner MJ. Regression and correlation. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 73-92.

Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 171-190.

Altman DG, Schulz KF. Concealing treatment allocation in randomised trials. British Medical Journal 2001; 323: 446-447.

Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001; 134: 663-694.

Chitty LS, Altman DG. Appendix: Charts of fetal size. In: Dewbury KC, Meire HB, Cosgrove DO, Farrant P (ed.) Ultrasound in Obstetrics and Gynaecology, 2nd ed. (Clinical Ultrasound: A Comprehensive Text, Vol 3.) London: Churchill Livingstone, 2001; 607-688.

Day SJ, Altman DG. Statistics notes: blinding in clinical trials and other studies. British Medical Journal 2000; 321: 504.

Deeks JJ, Altman DG. Effect measures for meta-analysis of trials with binary outcomes. In: Egger M, Davey Smith G, Altman DG (ed.) Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd ed. London: BMJ Books, 2001; 313-335.

Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (ed.) Systematic Reviews in HealtCare: Meta-Analysis in Context, 2nd ed. London: BMJ Books, 2001; 285-312.

Egger M, Davey Smith G, Altman DG (ed.) Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd ed. London: BMJ Books, 2001.

Gardner MJ, Altman DG. Confidence intervals rather than P values. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 15-27.

Gardner MJ, Altman DG. Estimating with confidence. In: Altman DG, Machin D, Bryant TN, Gardner MJ (ed.) Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. London: BMJ Books, 2000; 3-5.

Jüni P, Altman DG, Egger M. Assessing the quality of randomised controlled trials. In: Egger M, Davey Smith G, Altman DG (ed.) Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd ed. London: BMJ Books, 2001; 87-108.

Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. British Medical Journal 2001; 323: 42-46.

Katso RMT, Manek S, Ganjavi H, Biddolph S, Charnock MFL, Bradburn M, Wells M, Ganesan TS. Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression. Clinical Cancer Research 2000; 6: 3271-3281.

Micallef INM, Apostolidis J, Rohatiner AZS, Wiggins C, Crawley CR, Foran JM, Leonhardt M, Bradburn M, Okukenu E, Salam A, Matthews J, Cavenagh JD, Gupta RK, Lister TA. Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematology Journal 2000; 1: 367-373.

Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. Journal of the American Medical Association 2001; 285: 1987-1991.

Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Medical Research Methodology 2001; 1: 2 (7pp) http://www.biomedcentral.com/1471-2288/1/2

Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Annals of Internal Medicine 2001; 134: 657-662.

Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-1194.

Rohatiner A, Radford J, Deakin D, Earl H, Love SB, Price O, Wilson A, Lister TA. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma. British Journal of Cancer 2001; 85: 29-35.

Rohatiner AZS, Bassan R, Raimondi R, Amess JAL, Arnott S, Personen A, Rodeghiero F, Barbui T, Bradburn MJ, Carter M, Lister TA. High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia. Annals of Oncology 2000; 11: 1007-1015.

Song FJ, Glenny AM, Altman DG. Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Controlled Clinical Trials 2000; 21: 488-497.